The human genome is comprised of billions of points of tiny genetic code. DNA sequencing enables researchers to decode these DNA fragments, helping uncover valuable genetic information that relates to our well-being. Until recently, though, the technology didn’t exist to accurately and quickly process, decode and analyze the human genome. In the last decade, DNA sequencing has been completely revolutionized.
Today, Next-Generation Sequencing (NGS) technology has made it possible to process and decode the entire human genome in as little as 24 hours. NGS technology applications enable unprecedented scalability and touch on all areas of DNA research, including whole genome sequencing and exome sequencing. These contemporary sequencing methods are much more sensitive, enabling clinicians and researchers alike to discover a greater volume of submicroscopic genetic mutations in our DNA.
Based on the Next Generation Sequencing (Ngs) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Next Generation Sequencing (Ngs) market covered in Chapter 5:
DNA Electronics Ltd.
QuantuMDx Group
Mayo Medical Laboratories and Mayo Clinic
Multiplicom NV
Sequenta, Inc.
InDecations Exchange Pte Ltd (INEX)
Response Genetics, Inc.
RainDance Technologies, Inc.
Quest Diagnostics
SeqLL, LLC
Illumina, Inc.
MolecularMD Corporation
Qiagen N.V.
DNASTAR, Inc.
Roche
In Chapter 6, on the basis of types, the Next Generation Sequencing (Ngs) market from 2015 to 2025 is primarily split into:
454-Sequencing
Illumina Sequencing
In Chapter 7, on the basis of applications, the Next Generation Sequencing (Ngs) market from 2015 to 2025 covers:
Oncology
Hereditary Disease Detection
Life Science
Emerging Application
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Next Generation Sequencing (NGS). Industry analysis & Market Report on Next Generation Sequencing (NGS) is a syndicated market report, published as Global Next Generation Sequencing (Ngs) Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Next Generation Sequencing (NGS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.